Free press releases distribution network?

Agency / Source: KDM Communications Ltd

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



Pro-Lab Diagnostics Launches Prolisa™ Cryptosporidium/Giardia Enzyme Immunoassay - Pro-Lab Diagnostics has developed a new enzyme immunoassay (EIA) for the qualitative detection of Cryptosporidium and Giardia lamblia antigens in human faecal specimens from patients displaying gastrointestinal symptoms - Pro-Lab.com
Pro-Lab Diagnostics Launches Prolisa™ Cryptosporidium/Giardia Enzyme Immunoassay

 

PRZOOM - /newswire/ - St Neots, Cambridgeshire, United Kingdom, 2012/02/24 - Pro-Lab Diagnostics has developed a new enzyme immunoassay (EIA) for the qualitative detection of Cryptosporidium and Giardia lamblia antigens in human faecal specimens from patients displaying gastrointestinal symptoms - Pro-Lab.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

The Prolisa™ Cryptosporidium/Giardia EIA kit offers precise results with high sensitivity and excellent specificity, enabling accurate diagnosis of infection.

Cryptosporidiosis is routinely diagnosed by microscopic analysis of stool samples using organic dyes or by immunostaining by direct fluorescent antibody, and can be difficult to detect. Similarly, Giardia infection is frequently misdiagnosed, relying on poorly performing antigen-based testing. Pro-Lab Diagnostics’ Prolisa™ Cryptosporidium/Giardia EIA is a convenient, rapid and easy-to-use method of detecting Cryptosporidium and G. lamblia. Supplied in a 96-well test size consisting of detachable stripwells, this manual assay uses monoclonal anti-Cryptosporidium and anti- G. lamblia antibodies to ensure excellent sensitivity and specificity for high value diagnostic results, and can also be performed on most automated platforms for increased workflow flexibility. Mark Reed, General Manager of Pro-Lab Diagnostics, commented: “The launch of the Cryptosporidium/Giardia EIA further extends the Prolisa product range, offering our customers a simple and cost-effective alternative means of testing for Cryptosporidiosis and Giardiasis with the back-up support of our team of application experts.”

About Pro-Lab Diagnostics

The Pro-Lab Group of companies (pro-lab.com) is dedicated to the provision of high quality, cost effective immunodiagnostic products and biological reagents to hospitals, private medical laboratories, veterinary laboratories, and other biological investigative laboratories. Pro-Lab Diagnostics is a privately held corporation founded in 1974 with its head office in Toronto, Canada and subsidiaries in the U.K. and U.S.A.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: KDM Communications Ltd

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Pro-Lab Diagnostics Launches Prolisa™ Cryptosporidium/Giardia Enzyme Immunoassay

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Sophie Woodward - KDM-Communications.com 
+44(0)15 1353 1613 uksupport[.]pro-lab.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any KDM Communications Ltd securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From KDM Communications Ltd / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

MDxHealth Announces Agreement with Istituto Diagnostico Varelli for Distribution of SelectMDx Throughout Central-South Italy
BD Veritor™ System Meets FDA’s New Performance Requirements for Rapid Influenza Antigen Detection Tests
Sub-Sahara Africa - Increase in Western Lifestyles Leads to Dire Need for Chronic Prescription Drugs Finds Frost & Sullivan
BD Initiates New Industry Alliance to Combat Rising Opioid Crisis
BTG and Society of Interventional Oncology to Explore Role of Minimally Invasive Therapies in Immuno-oncology
Ipsen to Acquire a Portfolio of Select Consumer Healthcare Products from Sanofi
BD Announces Early Access Program for BD Resolve™ Single-Cell Analysis Platform
Precision Medicine Unlocks the Future of Targeted Therapy in the Global Healthcare Industry Finds Frost & Sullivan
Sciformix Corporation Receives Prestigious 2017 Global Outsourcing Customer Service Leadership Award from Frost & Sullivan
Arven Pharmaceuticals Selects GE Healthcare’s FlexFactory to Improve Turkish and Regional Access to Biopharmaceuticals

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  BizJobs.com

Visit  JobsWare.com

Visit  NAKIVO, Inc.







 
  ©2017 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today